Clinical Trial Update: Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase I study of the investigational drug GSK1550188 in Japanese subjects with systemic lupus erythematosus, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• GSK1550188

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED